Telerehabilitation Program for Stroke
(CARE-CITE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to assist stroke survivors and their family caregivers with home recovery. The aim is to determine if a web-based program, called CARE-CITE, can engage family members in the rehabilitation process without overwhelming them. It involves two main groups: one for caregivers and one for stroke survivors, each receiving either virtual therapy or traditional written materials. This trial may be suitable if a stroke occurred in the past 3 months to 2 years and assistance with daily activities is needed, with a caregiver living in the same home. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance home-based stroke recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this telerehabilitation program is safe for stroke survivors and care partners?
Research has shown that telerehabilitation programs like CARE-CITE are generally safe and well-received by participants. Studies have found that these programs often achieve similar or even better results compared to traditional therapy, indicating they don't pose significant safety concerns.
The CARE-CITE program specifically involves family members in the rehabilitation process. It has shown promising results in improving both the mental health of family members and the physical abilities of stroke survivors. Past studies with similar programs have reported no major negative events.
While detailed data on the safety of CARE-CITE itself is lacking, its nature as a web-based education program suggests a low risk of harmful effects. These programs usually focus on teaching and guidance rather than direct physical treatment, reducing the chance of side effects.12345Why are researchers excited about this trial?
Researchers are excited about the Telerehabilitation Program for Stroke because it takes stroke recovery into the digital age with its virtual Collaborative Integrated Therapy (CARE-CITE). Unlike standard treatments that often rely on in-person therapy sessions or traditional educational materials, CARE-CITE offers a convenient, remote program that supports both stroke survivors and their care partners through an interactive, family-centered approach. This method not only provides flexibility, reducing the need for travel to therapy sessions, but also emphasizes the role of family in recovery, potentially enhancing the overall rehabilitation process. By leveraging technology, this program aims to make stroke rehabilitation more accessible and engaging, which could lead to better outcomes for patients and their families.
What evidence suggests that the CARE-CITE program is effective for stroke rehabilitation?
This trial will evaluate the effectiveness of the CARE-CITE telerehabilitation program for stroke recovery. Studies have shown that telerehabilitation programs like CARE-CITE can be as effective, or even more so, than traditional in-person therapy for improving movement skills. Research indicates that learning about stroke prevention through telerehabilitation increases knowledge by 39%. This type of program also enhances overall recovery outcomes. One study found that telerehabilitation significantly benefited family caregivers, making it a promising option for involving care partners. These findings support the effectiveness of CARE-CITE in aiding stroke survivors and their families. Participants in this trial will be divided into groups receiving either the CARE-CITE program or traditional educational materials.23467
Who Is on the Research Team?
Sarah Blanton, PT, DPT
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for stroke survivors and their family members who help with daily care. Participants must be adults, have internet access, and a family member willing to join the study. People can't participate if they have conditions that would interfere with using the web-based program or are already receiving similar rehabilitation services.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the CARE-CITE program or attention control materials for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- CARE-CITE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator